Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

Drug Designing: Open Access : Citations & Metrics Report

Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.

Following are the list of articles that have cited the articles published in Drug Designing: Open Access.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Total published articles

22 32 30 31 67 2 5 16 18 12 14 24 6

Research, Review articles and Editorials

0 2 2 24 33 0 4 15 15 12 10 25 6

Research communications, Review communications, Editorial communications, Case reports and Commentary

14 30 27 7 35 2 1 1 3 0 4 3 0

Conference proceedings

0 5 5 0 0 0 124 81 41 56 0 0 58

Citations received as per Google Scholar, other indexing platforms and portals

45 51 54 62 43 41 41 23 48 16 10 5 0
Journal total citations count 456
Journal impact factor 1.70
Journal 5 years impact factor 1.5
Journal cite score 1.57
Journal h-index 9
Journal h-index since 2019 7
Important citations (297)

Optimisation of ethosomal nanogel for topical nano-cur and sulphoraphane delivery in effective skin cancer therapy

A bioassay system for pharmacological standardization of withania somnifera derived herbal remedies

Triethylene glycol-like effects of ashwagandha (withania somnifera (l.) dunal) root extract devoid of withanolides in stressed mice

Conducting clinical trials in emerging markets of sub-saharan africa: review of guidelines and resources for foreign sponsors

Design, synthesis, antitubercular and antimicrobial activities of novel thiazole substituted benzimidazole derivatives

Fast dissolving drug delivery system: a review

Principles involved in bioassay by different methods: a mini-review

Licofelone, a potent cox/5-lox inhibitor and a novel option for treatment of neurological disorders

Stat3 transcription factor as target for anti-cancer therapy

De-novo ligand design against mutated huntington gene by ligand-based pharmacophore modeling approach

Vibrational analysis and molecular docking studies on some ribonuclease-h hiv inhibitors

Evaluation of pterin, a promising drug candidate from cyanide degrading bacteria.

Combinatorial analysis of gene regulatory network reveals the causal genetic basis of breast cancer and gene-specific personalized drug treatments

Cancer treatment by caryophyllaceae-type cyclopeptides.

Peptides with dual antimicrobial-anticancer activity derived from the n-terminal region of h. pylori ribosomal protein l1 (rpl1)

Fast dissolving drug delivery system: a review

On the critical review of five machine learning-based algorithms for predicting protein stability changes upon mutation

A critical review of five machine learning-based algorithms for predicting protein stability changes upon mutation.

Review on: adverse drug reactions of chemotherapy drugs

A review on targeted drug delivery system - nanoparticles

Top